[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@MSollender Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1063180083769176064.png) @MSollender Michelle Solly

Michelle Solly posts on X about $rare, $mreo, $apge, $capr the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1063180083769176064/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXXX +114%
- X Months XXXXXXXXX +12%
- X Year XXXXXXXXX +351%

### Mentions: XX [#](/creator/twitter::1063180083769176064/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX -XX%
- X Year XXX +345%

### Followers: XXXXXX [#](/creator/twitter::1063180083769176064/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:followers.svg)

- X Week XXXXXX +0.09%
- X Month XXXXXX +1.50%
- X Months XXXXXX +6.40%
- X Year XXXXXX +9.60%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1063180083769176064/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1063180083769176064/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX% [stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[$rare](/topic/$rare) #36, [$mreo](/topic/$mreo) #5, [$apge](/topic/$apge) #3, [$capr](/topic/$capr) #2, [$cogt](/topic/$cogt) #1, [$fulc](/topic/$fulc) #1, [$mltx](/topic/$mltx) #8, [$omer](/topic/$omer) #103, [$argx](/topic/$argx) #4, [$pali](/topic/$pali) XXXX%

**Top accounts mentioned or mentioned by**
[@crocsanalyst](/creator/undefined) [@a_may_md](/creator/undefined) [@joserestonva](/creator/undefined) [@bluejaunt100](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@biotenic](/creator/undefined) [@amaymd](/creator/undefined) [@jq1234t](/creator/undefined) [@martinshkreli](/creator/undefined) [@biotechport](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@oncinvestor](/creator/undefined) [@prosperousguy](/creator/undefined) [@gravityanalyti1](/creator/undefined) [@vega_n1](/creator/undefined) [@monaco_biotech](/creator/undefined) [@pickingmyown](/creator/undefined) [@snupsnus](/creator/undefined) [@longonlybio](/creator/undefined) [@sportsbios](/creator/undefined)

**Top assets mentioned**
[SuperRare (RARE)](/topic/$rare) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Edgewise Therapeutics, Inc. Common Stock (EWTX)](/topic/$ewtx) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Immunovant, Inc. Common Stock (IMVT)](/topic/$imvt) [Incyte Corporation (INCY)](/topic/$incy) [Insmed, Inc. (INSM)](/topic/$insm) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Mist (MIST)](/topic/$mist) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Alkermes Inc. plc (ALKS)](/topic/$alks) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [United Therapeutics, Corp. (UTHR)](/topic/united-therapeutics-corp)
### Top Social Posts [#](/creator/twitter::1063180083769176064/posts)
---
Top posts by engagements in the last XX hours

"$PALI Palisade Bio Announces Closing of Upsized $XXX Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option"  
[X Link](https://x.com/MSollender/status/1973842600017998139) [@MSollender](/creator/x/MSollender) 2025-10-02T20:08Z 13.6K followers, 6976 engagements


"$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis"  
[X Link](https://x.com/MSollender/status/1943039211726344343) [@MSollender](/creator/x/MSollender) 2025-07-09T20:07Z 13.6K followers, 16.8K engagements


"$GLTO $ACXP $XBIO What are we doing here"  
[X Link](https://x.com/MSollender/status/1975844511038546426) [@MSollender](/creator/x/MSollender) 2025-10-08T08:43Z 13.6K followers, 6686 engagements


"(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE"  
[X Link](https://x.com/MSollender/status/1940005423534547058) [@MSollender](/creator/x/MSollender) 2025-07-01T11:11Z 13.6K followers, 70.9K engagements


"(2/3) Some intriguing make-or-break data sets for companies as well as some modality readouts are upcoming $DRUG $DYN $ELDN $EWTX $FGEN $FULC $GPCR $IFRX $IMNM $IMVT $INCY $INSM $IRON $JANX $JAZZ $KRRO $LXEO $MIST $MLTX $MREO $MRSN $NKTR"  
[X Link](https://x.com/MSollender/status/1973339816294285641) [@MSollender](/creator/x/MSollender) 2025-10-01T10:50Z 13.6K followers, 3927 engagements


"The Shkreli effect 🍿"  
[X Link](https://x.com/MSollender/status/1975266135965839843) [@MSollender](/creator/x/MSollender) 2025-10-06T18:25Z 13.6K followers, 79.9K engagements


"(3/3) And last but not least Also a few events that might carry over into 1Q 2026 $OMER $OVID $PHVS $PRAX $PRQR $PVLA $RARE $RNA $RNAC $RPTX $RYTM $RZLT $SKYE $SRPT $SYRE $TVRD $VTGN $VTYX $WVE $ZBIO $AVXL $VALN"  
[X Link](https://x.com/MSollender/status/1973340119957643782) [@MSollender](/creator/x/MSollender) 2025-10-01T10:52Z 13.6K followers, 6557 engagements


"Forgot this one: $IDYA Darovasertib + Crizotinib Ph2/3 in 1L HLA-A2-neg MUM by YE25 (median PFS Data)"  
[X Link](https://x.com/MSollender/status/1973344566309953767) [@MSollender](/creator/x/MSollender) 2025-10-01T11:09Z 13.6K followers, 2817 engagements


"$ARGX argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG Study met primary endpoint (p-value=0.0068)"  
[X Link](https://x.com/MSollender/status/1959859288467521558) [@MSollender](/creator/x/MSollender) 2025-08-25T06:04Z 13.6K followers, 7635 engagements


"(1/3) It's the home stretch for 2025 already Here are some catalysts for 4Q25 and in red some that I have my eye on Let me know if I missed your favorite event $AGIO $ALEC $ALKS $ANAB $APGE $ARGX $BBIO $BDTX $BHVN $BLTE $CABA $CAPR $CELC $CGEM $CNTA $COGT $CRBP $CYTK"  
[X Link](https://x.com/MSollender/status/1973339349103288786) [@MSollender](/creator/x/MSollender) 2025-10-01T10:48Z 13.6K followers, 19.8K engagements


"$UTHR United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis"  
[X Link](https://x.com/MSollender/status/1962833935563665717) [@MSollender](/creator/x/MSollender) 2025-09-02T11:04Z 13.6K followers, 3272 engagements